This inventor holds 2 USPTO granted patents. Top assignee: Virginia Commonwealth University. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Rajesh Karuturi: Innovator in Cancer Therapeutics and Anticoagulant Agents
Introduction
Rajesh Karuturi is a prominent inventor based in Richmond, VA (US). He has made significant contributions to the field of cancer therapeutics and anticoagulant agents. With a total of 2 patents, his work focuses on innovative solutions to pressing medical challenges.
Latest Patents
Karuturi's latest patents include groundbreaking research on sulfated and unsulfated flavonoid oligomers as cancer therapeutics. These compounds have been shown to selectively inhibit cancer stem cells (CSCs) growth and self-renewal both in vitro and in vivo. Additionally, he has developed allosteric modulators of factor XIa as anticoagulant agents. These compounds, which include sulfated gallolyl glucosides, sulfated quinazolinones, and sulfated inositol analogs, are designed to modulate and inhibit factor XIa activity, providing new methods for anticoagulation.
Career Highlights
Karuturi is affiliated with Virginia Commonwealth University, where he continues to advance his research. His work has garnered attention for its potential impact on cancer treatment and blood coagulation disorders.
Collaborations
He collaborates with notable colleagues such as Umesh R Desai and Bhaumik B Patel, contributing to a dynamic research environment that fosters innovation.
Conclusion
Rajesh Karuturi's contributions to the fields of cancer therapeutics and anticoagulant agents highlight his role as a leading inventor. His innovative patents reflect a commitment to addressing critical health issues through scientific research and collaboration.